Current Edition

applications

Recent FDA Advancements in Rare Diseases – Funding, Partnerships, and Programs

The paucity of therapeutic choices is a reality often acknowledged by the US Food and Drug Administration (FDA) as it reviews applications for new medical …

Continue Reading →
approved

Learning From The Past

How Sharing Clinical Science Research During the Pandemic has better Prepared Us for The Future “The scientific community working together can do some pretty amazing …

Continue Reading →
behavioural therapy

Deep Brain Stimulation Could Address Suicide Risk in Individuals Resistant to Treatment

Pharmaceutical and behavioural therapy treatments have successfully helped many patients manage symptoms of mental health conditions, such as major depressive disorder (MDD), posttraumatic stress disorder …

Continue Reading →
2018

Lilly to Present Phase 3 Data at AHS 2018 Highlighting Innovative Potential Treatments for Migraine and Cluster Headache

Eli Lilly and Company (NYSE: LLY) announced today it will present Phase 3 data for galcanezumab and lasmiditan, two investigational, non-opioid treatments for migraine and cluster …

Continue Reading →